Stocks · Health care · Biological Products, (No Diagnostic Substances)

LeonaBio, Inc.

LONA Clue Score29
United States Fiscal year ends December CIK 0001620463 Results filed 14 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Perceptive Advisors LLC
26 Oct 2026
Director
Exercised, kept indirect
776,648
$0.00
$776.65
David J. Portman
26 Oct 2026
10% owner
Buy indirect
3,149,470
$3,149.47
left out
Martin Javier San
4 Mar 2026
Chief Medical Officer
Sell
1,720
$5.37
$9.24K
Kevin Church
4 Mar 2026
Chief Scientific Officer
Sell
1,359
$5.37
$7.30K
Mark Worthington
4 Mar 2026
GENERAL COUNSEL and CCO
Sell
1,328
$5.37
$7.13K
Robert Renninger
4 Mar 2026
Chief Financial Officer
Sell
906
$5.37
$4.87K
Mark James Litton
4 Mar 2026
PRESIDENT and CEO
Sell
5,156
$5.37
$27.69K
Mark Worthington
2 Jan 2026
General Counsel and CCO
Sell
876
$6.88
$6.03K
Kevin Church
2 Jan 2026
Chief Scientific Officer
Sell
876
$6.88
$6.03K
Robert Renninger
2 Jan 2026
Chief Financial Officer
Sell
297
$6.88
$2.04K
Mark James Litton
2 Jan 2026
President and CEO
Sell
2,586
$6.88
$17.79K
Martin Javier San
2 Jan 2026
Chief Medical Officer
Sell
1,644
$6.88
$11.31K

What was left out

Form 4 filings counted 44
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 10
Transactions with no price 1
Shares from compensation/vesting 2,166,899
History held since 22 Sep 2020